NCT02295332View on ClinicalTrials.gov

A Study of RG7625 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Matching oral placebo capsules to RG7625, according to treatment schedule

DRUG

RG7625

oral administration, capsules, single ascending dose according to treatment schedule

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02295332 - A Study of RG7625 in Healthy Volunteers | Biotech Hunter | Biotech Hunter